The expression of Tau in PS19 mice is five-fold higher than endogenous levels, and they develop hallmarks of Alzheimer's disease including neuronal loss in the hippocampus, spreading the neocortex and entorhinal cortex. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.